Ideally : Actualité Ideally en direct - P1 | Bourse Reflex
Accueil > Tags > Ideally

  • Toutes les actualités en rapport avec « Ideally »

15/03 17:45 Ideally - 2016 financial results : Revenue: +19.2% - Current operating margin target exceeded : 9.7% - Group net income: +32.6% to EUR 21.3 million

20/02 18:00 Ideally - SHARP ACCELERATION IN GROWTH IN 2016 AND STRONG OUTLOOK FOR 2017

12/12 08:30 Ideally - Funds advised by Apax Partners LLP acquire remaining stake in European medical diagnostics leader Unilabs from Nordic Capital and Apax Partners France

06/12 18:00 Ideally - H1 2016-2017: CONTINUED STRONG GROWTH IN RESULTS NET PROFIT: +17%

26/10 19:45 Ideally - ASK and Paragon Group enter into a memorandum of understanding with a view to the merger of ASK with Paragon's Identification Division

21/09 17:00 Ideally - PRE-IPO : Launch of AlzProtect's fundraising

15/06 19:30 Ideally - GENTICEL TO PRESENT CLINICAL RESULTS OF GTL001 AND PRECLINICAL RESULTS OF GTL002 AT EUROGIN 2016 CONGRESS IN SALZBURG, AUSTRIA

13/06 18:35 Ideally - GENTICEL ANNOUNCES COMPLETION OF TWO MAJOR MILESTONES IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

08/06 18:35 Ideally - Disclosure of the total number of voting rights and shares composing the share capital

01/06 19:00 Ideally - GENTICEL ANNOUNCES PUBLICATION IN 'CLINICAL CANCER RESEARCH' OF PHASE 1 TRIAL RESULTS SUPPORTING SAFETY, TOLERABILITY AND IMMUNOGENICITY OF GTL001

11/05 08:00 Ideally - Disclosure of the total number of voting rights and shares composing the share capital

03/05 18:00 Ideally - 2015-2016: an excellent vintage - Strong growth in revenues: +24%

28/04 18:35 Ideally - BUSINESS UPDATE - FIRST QUARTER 2016

26/04 18:35 Ideally - PUBLICATION OF THE 2015 ANNUAL FINANCIAL REPORT

21/04 19:45 Ideally - PUBLICATION OF THE FIRST ISSUE OF GENTICEL'S SHAREHOLDER NEWSLETTER

21/04 18:20 Ideally - 2015 Annual Results

20/04 18:30 Ideally - GENTICEL REPORTS ADDITIONAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

06/04 18:00 Ideally - Disclosure of the total number of voting rights and shares composing the share capital

14/03 07:00 Ideally - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

10/03 18:30 Ideally - GENTICEL UPDATES ITS FINANCIAL CALENDAR FOR 2016 AND ANNOUNCES PARTICIPATION IN KEY CONFERENCES IN H1 2016